Page last updated: 2024-12-08

ribulose 5-phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ribulose 5-phosphate: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

D-ribulose 5-phosphate : The D-enantiomer of ribulose 5-phosphate that is one of the end-products of the pentose phosphate pathway. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

ribulose 5-phosphate : A ribulose phosphate in which the phosphate group is attached at position 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439184
CHEBI ID17363
SCHEMBL ID49528
MeSH IDM0098979

Synonyms (33)

Synonym
5-o-phosphono-d-ribulose
CHEBI:17363
d-erythro-pent-2-ulose 5-(dihydrogen phosphate)
5rp ,
ribulose-5-phosphate
erythro-2-pentulose, 5-(dihydrogen phosphate)
d-erythro-pentulose, 5-(dihydrogen phosphate) (8ci)
d-ribulose-5-phosphate
d-erythro-pentulose, 5-phosphate (6ci,7ci)
d-erythro-2-pentulose, 5-(dihydrogen phosphate)
551-85-9
C00199
4151-19-3
d-ribulose 5-phosphate
589F6EA7-AA2C-4B43-BE6F-85E0B24E64C9
ribulose 5-phosphate
[(2r,3r)-2,3,5-trihydroxy-4-oxopentyl] dihydrogen phosphate
SCHEMBL49528
J-002113
erythro-pentulose 5-phosphate
ribulose phosphate
d-ribulose-5-phosphoric acid
Q35671055
rel-(2r,3r)-2,3,5-trihydroxy-4-oxopentyl dihydrogen phosphate
rel-(2r,3r)-2,3,5-trihydroxy-4-oxopentyldihydrogenphosphate
d-erythro-pentulose, 5-(dihydrogen phosphate)
d-erythro-pentulose, 5-phosphate
thu37vtp7y ,
unii-thu37vtp7y
((2r,3r)-2,3,5-trihydroxy-4-oxopentyl) dihydrogen phosphate
DTXSID001336250
DTXSID301336247
(2r,3r)-2,3,5-trihydroxy-4-oxopentyl dihydrogen phosphate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
ribulose 5-phosphateA ribulose phosphate in which the phosphate group is attached at position 5.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (27)

PathwayProteinsCompounds
Pentose Phosphate Pathway1527
Glucose-6-phosphate Dehydrogenase Deficiency1527
Ribose-5-phosphate Isomerase Deficiency1527
Transaldolase Deficiency1527
Warburg Effect4652
Lipopolysaccharide Biosynthesis4153
Lipopolysaccharide Biosynthesis II4053
Flavin Biosynthesis1024
Ketogluconate Metabolism1017
Lipopolysaccharide Biosynthesis III3352
Xylitol Degradation917
Riboneogenesis511
CMP-3-Deoxy-D-Manno-Octulosonate (CMP-Kdo) Biosynthesis411
Photosynthesis6324
Calvin-Benson Cycle1321
Pentose phosphate cycle ( Pentose phosphate cycle )2225
D-Ribose 5-phosphate = D-Ribulose 5-phosphate ( Pentose phosphate cycle )12
Metabolic reprogramming in pancreatic cancer4223
superpathway of central carbon metabolism346
formaldehyde assimilation II (RuMP Cycle)014
CMP-KDO biosynthesis I010
superpathway of gluconate degradation48
Carbon assimilation C4 pathway030
Relationship between glutathione and NADPH036
Pentose phosphate pathway 2011
Metabolism overview078
Biochemical pathways: part I0466

Research

Studies (86)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (17.44)18.7374
1990's21 (24.42)18.2507
2000's25 (29.07)29.6817
2010's20 (23.26)24.3611
2020's5 (5.81)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.93 (24.57)
Research Supply Index4.48 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index132.70 (26.88)
Search Engine Supply Index3.69 (0.95)

This Compound (46.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (4.60%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other83 (95.40%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]